Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270873 Adamantyl diamide derivatives and uses of same
10/25/2012US20120270872 Crystalline Forms of N-[3-fluoro-4-(oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
10/25/2012US20120270871 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270869 Pyridyl derivatives as cftr modulators
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270867 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/25/2012US20120270866 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
10/25/2012US20120270865 Heterocyclic compound
10/25/2012US20120270864 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270860 Methods for treating or preventing alcohol-related disorders or craving-related disorders
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270857 5-ht3 receptor modulators, methods of making, and use thereof
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270854 Antiviral Compounds
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270851 Use of ferroquine in the treatment or prevention of malaria
10/25/2012US20120270850 Metal delivery agents and therapeutic uses of the same
10/25/2012US20120270849 Combinations of niacin, omega-3 and plant sterols/stanols for prevention cholesterol treatment
10/25/2012US20120270848 Novel Compositions and Therapeutic Methods Using Same
10/25/2012US20120270847 Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof
10/25/2012US20120270846 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270844 Methods for treating alzheimer's disease
10/25/2012US20120270843 Pesticide composition comprising propamocarb-fosetylate and an insecticidally active substance
10/25/2012US20120270842 Inhibitors of Diacylglycerol O-Acyltransferase 1 (DGAT-1) and Uses Thereof
10/25/2012US20120270841 Diazonamide Analogs
10/25/2012US20120270840 Proteasome inhibitors and processes for their preparation, purification and use
10/25/2012US20120270839 Compositions and methods for cancer treatment
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270837 Compositions that treat or inhibit pathological conditions associated with inflammatory response
10/25/2012US20120270836 Therapeutic approaches for treating alzheimer's disease
10/25/2012US20120270835 Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same
10/25/2012US20120270834 Depolymerized glycosaminoglycan from thelenota ananas and preperation method thereof
10/25/2012US20120270833 Immune activation of green tea hydrolysate and method for preparing food composition containing the same
10/25/2012US20120270832 Ketone accumulation inhibitor
10/25/2012US20120270831 Method for treating hematopoietic neoplasms
10/25/2012US20120270830 Nutritional compositions including theanine and exogenous nucleotides
10/25/2012US20120270829 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/25/2012US20120270828 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv)
10/25/2012US20120270827 Indole Antiviral Compositions And Methods
10/25/2012US20120270826 Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions
10/25/2012US20120270825 Salix extract, its use and formulations containing it
10/25/2012US20120270824 Mannose derivatives as antagonists of bacterial adhesion
10/25/2012US20120270823 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
10/25/2012US20120270822 Stabilized formulation for oral administration of therapeutic agents and related methods
10/25/2012US20120270821 CDK5 Inhibitors and Therapeutic Uses Thereof
10/25/2012US20120270820 Use of albiflorin for anti-depression
10/25/2012US20120270819 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone disease
10/25/2012US20120270818 Hdac 6 inhibitor-based methods for treating cancer
10/25/2012US20120270817 6-Substituted Estradiol Derivatives and Methods of Use
10/25/2012US20120270816 Methods of diagnosing and treating migraine
10/25/2012US20120270815 Modified-galactosyl ceramides for staining and stimulating natural killer t cells
10/25/2012US20120270814 Compositions and methods for reducing or preventing obesity
10/25/2012US20120270803 Mitotic Kinesin Inhibitors and Methods of Use Thereof
10/25/2012US20120270799 METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS
10/25/2012US20120270795 Compounds for the treatment of diseases related to protein misfolding
10/25/2012US20120270783 Rapid opioid detoxification
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270780 Method and composition for modulating erythropoiesis
10/25/2012US20120270773 Trim5alpha mutants and uses thereof
10/25/2012US20120270736 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
10/25/2012US20120269908 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
10/25/2012US20120269906 Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
10/25/2012US20120269903 Novel mannopyranoside derivatives with anticancer activity
10/25/2012US20120269902 Thiazole Compounds, and Compositions and Methods Using Same
10/25/2012US20120269901 Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
10/25/2012US20120269898 Compositions and methods of treating pulmonary hypertension
10/25/2012US20120269897 Poly(tetrafluoroethylene) polymer with nitric oxide donating surface
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269891 Controlled release oral pharmaceutical dosage forms comprising mgbg
10/25/2012US20120269890 Process for obtaining a rosuvastatin calcium composition and obtained product
10/25/2012US20120269889 Non-gelatin soft capsule system
10/25/2012US20120269888 Barrier composition
10/25/2012US20120269887 Pomegranate fruit polyphenol composition and methods of use and manufacture thereof
10/25/2012US20120269886 Therapeutic agent for pulmonary fibrosis
10/25/2012US20120269883 MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/25/2012US20120269881 Transdermal drug delivery device including an occlusive backing
10/25/2012US20120269878 Composition For Transdermal Delivery Of Fentanyl
10/25/2012US20120269874 Compositions for topical application comprising a peroxide and retinoid
10/25/2012US20120269872 Novel salt 628
10/25/2012US20120269871 Solid state forms of rasagiline salts
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269867 Methods of treating central nervous system tumors
10/25/2012US20120269866 Gastroretentive Composition On The Basis Of A Water-Soluble Reaction Product From A Vinyl Group-Containing Precursor
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/25/2012US20120269863 Methods and compositions for regulating lymphocyte activity
10/25/2012US20120269861 Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agents
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269857 Analogs of alpha galactosylceramide and uses thereof
10/25/2012US20120269850 Method of Inducing an Immune Response
10/25/2012US20120269848 Compositions and methods for treating and preventing infection
1 ... 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 ... 7860